Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             166 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparative analysis of striatal and extrastriatal D2/D3 binding of five pharmacologically different “atypical” antipsychotics Gründer, Gerhard
 2006
 31 S2 p. T121-
1 p.
 artikel
2 A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635 Cselényi, Zsolt
 2006
 31 S2 p. T86-
1 p.
 artikel
3 Acute systemic lipopolysaccharide (LPS) produces regional changes in brain sigma-1 receptors as measured with [18F]2-Flouropropyl-[(4-cyanophenoxy)methyl]piperidine ([18F]FPS) in the rat Waterhouse, Rikki N.
 2006
 31 S2 p. T177-
1 p.
 artikel
4 Acute systemic lipopolysaccharide (LPS) produces regional changes in brain Sigma-1 receptors as measured with [18F]2-Flouropropyl-[(4-cyanophenoxy)methyl]piperidine ([18F]FPS) in the rat Waterhouse, Rikki N.
 2006
 31 S2 p. T147-
1 p.
 artikel
5 Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors—a PET study in schizophrenia Mizrahi, Romina
 2006
 31 S2 p. T178-T179
nvt p.
 artikel
6 Agonist-mediated internalization of dopamine D2 receptors does not appear to mediate the decrease in benzamides binding potential observed after dopamine surge Jiang, Man
 2006
 31 S2 p. T32-
1 p.
 artikel
7 A hybrid wavelet-ICA model for dynamic PET analysis Su, Hong-Ren
 2006
 31 S2 p. T67-T68
nvt p.
 artikel
8 Alterations in GABAA receptor kinetics in epileptic rats studied in vivo using positron emission tomography Liefaard, Lia C.
 2006
 31 S2 p. T145-
1 p.
 artikel
9 Amphetamine-induced dopamine release: Duration of action as assessed by the dopamine-2-receptor (D2) agonist [11C]NPA in baboons Narendran, Raj
 2006
 31 S2 p. T118-
1 p.
 artikel
10 A new PET radioligand [11C]cyclopropyl-FLB 457 for imaging extrastriatal dopamine D2 receptors: Evaluation in monkey and comparison to [11C]FLB 457 and [11C]Fallypride Airaksinen, Anu J.
 2006
 31 S2 p. T15-
1 p.
 artikel
11 An improved method for voxel-based partial volume correction in PET and SPECT Erlandsson, Kjell
 2006
 31 S2 p. T84-
1 p.
 artikel
12 A novel reference tissue approach for multiple injections of [C-11]raclopride Watabe, Hiroshi
 2006
 31 S2 p. T73-
1 p.
 artikel
13 A novel reference tissue model for Bmax and KD estimation Erlandsson, Kjell
 2006
 31 S2 p. T17-
1 p.
 artikel
14 Assessment of brain tissue hypoxia during and after MCA occlusion in the rat using 18F-fluoromisonidazole (F-MISO) and microPET Takasawa, Masashi
 2006
 31 S2 p. T149-
1 p.
 artikel
15 Assessment of microglial activation in mild cognitive impairment using [11C](R)-PK11195 and PET Schuitemaker, Alie
 2006
 31 S2 p. T159-
1 p.
 artikel
16 Association between reduced striatal D2 receptor binding and the estimated time to onset in presymptomatic Huntington's disease: A longitudinal RAC/PET study over 4 years Ma, Yilong
 2006
 31 S2 p. T162-
1 p.
 artikel
17 Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: A PET study in nonhuman primate brain using ( S , S )-[18F]FMeNER-D2 Seneca, Nicholas
 2006
 31 S2 p. T28-
1 p.
 artikel
18 Automatic definition of image-derived input functions in brain PET images using clustering based on population arterial blood curves Lubberink, Mark
 2006
 31 S2 p. T69-
1 p.
 artikel
19 Automatic extraction of VOI data from functional images Svarer, Claus
 2006
 31 S2 p. T91-
1 p.
 artikel
20 Awareness in visuo-verbal perception is linked to dopamine release Lou, Hans
 2006
 31 S2 p. T176-
1 p.
 artikel
21 Basis function approach to the evaluation of the limits of applicability of graphical methods in the analysis of very-high-affinity PET ligands Graner, John L.
 2006
 31 S2 p. T70-
1 p.
 artikel
22 Bayesian kinetic modelling Gunn, Roger
 2006
 31 S2 p. T71-
1 p.
 artikel
23 Binding of the hallucinogen [11C]MeO-DMT in the brain of living pigs Pedersen, Kasper
 2006
 31 S2 p. T53-
1 p.
 artikel
24 [11C]DASB imaging of serotonin transporters in alcoholic patients Brown, Amira
 2006
 31 S2 p. T166-
1 p.
 artikel
25 [11C]DASB PET imaging of serotonin transporters in unmedicated patients with early onset obsessive compulsive disorder Ichise, Masanori
 2006
 31 S2 p. T167-
1 p.
 artikel
26 Cerebral nicotinic acetylcholine receptors in patients with Alzheimer's disease assessed with 2-[18F]F-A85380 PET—correlations to dementia severity Kendziorra, Kai
 2006
 31 S2 p. T39-
1 p.
 artikel
27 Cerebral nicotinic acetylcholine receptors in the periventricular white matter in patients with Alzheimer's disease and vascular dementia—a 2-[18F]F-A85380 PET investigation Kendziorra, Kai
 2006
 31 S2 p. T150-
1 p.
 artikel
28 [11C]GSK224558 as a potential PET ligand for the delineation of 5-HT6 receptors Huiban, Mickael
 2006
 31 S2 p. T13-
1 p.
 artikel
29 Changes of [11C]DASB binding in human brain after citalopram infusion Hinz, Rainer
 2006
 31 S2 p. T26-
1 p.
 artikel
30 Comparison of parametric imaging methods for [11C]-DASB serotonin transporter binding studies Bovo, Valentina
 2006
 31 S2 p. T82-
1 p.
 artikel
31 Comparisons of central benzodiazepine receptor mapping tracers [18F]Flumazenil and [11C]Flumazenil presentation Odano, Ikuo
 2006
 31 S2 p. T88-
1 p.
 artikel
32 Competition for endogenous serotonin with serotoin re-uptake inhibitors measured with PET Lundquist, Pinelopi
 2006
 31 S2 p. T130-
1 p.
 artikel
33 Cortical D1 across COMT genotypes Abi-Dargham, Anissa
 2006
 31 S2 p. T40-
1 p.
 artikel
34 Databasing molecular neuroimaging studies Nielsen, Finn Årup
 2006
 31 S2 p. T184-
1 p.
 artikel
35 Data-driven volume of interest definition: Benefits and pitfalls Boellaard, Ronald
 2006
 31 S2 p. T63-
1 p.
 artikel
36 Detection of alpha-2 adrenergic receptors in brain of living pig with [11C]yohimbine Jakobsen, Steen
 2006
 31 S2 p. T123-T124
nvt p.
 artikel
37 Determination of the plasma input function of [18F]altanserin by selective liquid–liquid extraction. Validation of a TLC method and comparison to HPLC Matusch, Andreas
 2006
 31 S2 p. T55-
1 p.
 artikel
38 Direct estimation of cumulative integrals of the input function for Logan plot in neuroreceptor imaging using intersection searching algorithm Naganawa, Mika
 2006
 31 S2 p. T89-T90
nvt p.
 artikel
39 Direct reconstruction of sinograms to parametric images of 18F-fallypride binding in monkey brain Kamasak, Mustafa
 2006
 31 S2 p. T92-
1 p.
 artikel
40 Dissociation between striatal alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2) and dopamine transporters (DAT) in Parkinson disease: A 2-[18F]-F-A-85380 PET/[123I]-FP-CIT SPECT study Meyer, Philipp
 2006
 31 S2 p. T157-
1 p.
 artikel
41 Distribution volume of the nicotinic acetylcholine receptor ligand 2-[F-18]F-A-85380: Nonsmokers versus smokers Herzog, Hans
 2006
 31 S2 p. T156-
1 p.
 artikel
42 Dopamine D2/D3 receptor occupancy of apomorphine evaluated with the agonist radioligand [11C]MNPA and the antagonist radioligand [11C]Raclopride. A PET evaluation in the non-human primate brain Finnema, Sjoerd
 2006
 31 S2 p. T120-
1 p.
 artikel
43 Dopamine transporter binding corrected for tissue heterogeneity and partial volume effect using [11C]PE2I and PET Odano, Ikuo
 2006
 31 S2 p. T87-
1 p.
 artikel
44 Dopamine transporter inhibitors: new potential ligands available? Audrain, Hélène
 2006
 31 S2 p. T52-
1 p.
 artikel
45 Dopamine transporter quantification by [123I]-SPECT—a future paraclinical tool? Ziebell, M.
 2006
 31 S2 p. T182-
1 p.
 artikel
46 Dopamin receptors, transporters, and amphetamine-induced release in late middle life Hiroto, Kuwabara
 2006
 31 S2 p. T113-
1 p.
 artikel
47 Drug-associated context increases dopamine release during placebo administration: A PET [11C]raclopride study in healthy volunteers Boileau, Isabelle
 2006
 31 S2 p. T112-
1 p.
 artikel
48 Duration of cyclosporin-induced P-glycoprotein inhibition in the blood–brain barrier can be studied with [11C]verapamil Syvänen, Stina
 2006
 31 S2 p. T109-
1 p.
 artikel
49 Editorial Board 2006
 31 S2 p. CO2-
1 p.
 artikel
50 Effect of acute and chronic inhibition of the DA transporter on DA synthesis and DA D2 receptors Urosevic, U.
 2006
 31 S2 p. T146-
1 p.
 artikel
51 Effect of acute systemic baclofen on amphetamine-stimulated striatal dopamine release as measured in rats with the dopamine D2D3 receptor agonist racer [3H]-(+)-PHNO Waterhouse, Rikki N.
 2006
 31 S2 p. T117-
1 p.
 artikel
52 Effect of the P-gp modulator, cyclosporin-A, on the disposition of the 5-HT1A receptor radioligand [11C](−)-RWAY in rodent brain and blood Liow, Jeih-San
 2006
 31 S2 p. T129-
1 p.
 artikel
53 Effects of alpha7-type nicotinic receptor agonist on cortical D1 receptor binding and PDE-IV activity modulated by chronic PCP treatment in conscious monkey brain Tsukada, Hideo
 2006
 31 S2 p. T36-
1 p.
 artikel
54 Effects of d -amphetamine on binding of the new D2/3 receptor agonist radioligand [11C]-(+)-PHNO in humans Willeit, Matthaeus
 2006
 31 S2 p. T31-
1 p.
 artikel
55 Effects of intravenous glucose on brain dopamine D2 receptor availability in obesity Haltia, Lauri T.
 2006
 31 S2 p. T161-
1 p.
 artikel
56 Effects of MR scanner type, scanning sequence and segmentation algorithm on MR-based partial volume corrections of [11C](R)-PK11195 studies Kloet, Reina W.
 2006
 31 S2 p. T83-
1 p.
 artikel
57 Estimation of D2-like dopamine receptor occupancy by dopamine in the MPTP primate model of Parkinson's disease Chefer, Svetlana
 2006
 31 S2 p. T144-
1 p.
 artikel
58 Evaluation of reference tissue models for the quantitative analysis of [11C]PE2I binding in human brain Seki, Chie
 2006
 31 S2 p. T19-
1 p.
 artikel
59 Extraction of time activity curves from positron emission tomography: K-means clustering or non-negative matrix factorization Bödvarsson, Bjarni
 2006
 31 S2 p. T185-T186
nvt p.
 artikel
60 Fast dynamic measurements of dopamine receptors with a three-headed SPECT system: A phantom study Vanzi, Eleonora
 2006
 31 S2 p. T94-
1 p.
 artikel
61 F-18 labeled PET agents for amyloid plaque imaging Kung, Mei-Ping
 2006
 31 S2 p. T51-
1 p.
 artikel
62 [18F]LBT-999, a new radioligand to study the dopamine transporter with PET: Characterization in baboons Saba, Wadad
 2006
 31 S2 p. T132-
1 p.
 artikel
63 Frontal dopamine D2 receptor binding in neuroleptic-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and gender Rasmussen, Hans
 2006
 31 S2 p. T170-
1 p.
 artikel
64 [3H]Gaboxadol binding sites characterised by in vitro autoradiography on pig brain and homogenate studies in rat Friemel, Anne
 2006
 31 S2 p. T139-
1 p.
 artikel
65 High sensation seeking men have increased dopamine binding in the right putamen during gambling, determined from raclopride binding potentials Peterson, Ericka
 2006
 31 S2 p. T168-
1 p.
 artikel
66 Hippocampal dopamine D2 receptors are involved in memory and frontal lobe functions Takahashi, Hidehiko
 2006
 31 S2 p. T37-
1 p.
 artikel
67 5-HT2A receptor binding in mild cognitive impairment: Correlation with cognitive and neuropsychiatric symptoms Hasselbalch, Steen Gregers
 2006
 31 S2 p. T38-
1 p.
 artikel
68 5-Hydroxy-l-(beta-11C)tryptophan or alpha-(11C)methyl-l-tryptophan for PET imaging of serotonin synthesis capacity in the Rhesus monkey brain Lundquist, Pinelopi
 2006
 31 S2 p. T133-
1 p.
 artikel
69 [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: Implications for the use of cerebellum as a reference region Pinborg, Lars H.
 2006
 31 S2 p. T20-
1 p.
 artikel
70 [I-123] 5-IA-85380 SPECT imaging of beta2-nicotinic acetylcholine receptors in recently abstinent mentally healthy and schizophrenic smokers Staley, Julie
 2006
 31 S2 p. T154-
1 p.
 artikel
71 Imaging endogenous dopamine occupancy of the D2 receptor in rat brain with [11C]MNPA Seneca, Nicholas
 2006
 31 S2 p. T119-
1 p.
 artikel
72 Imaging of the progression of nigrostriatal deficit in early-onset parkin disease with [123I]FP-CIT SPECT Varrone, Andrea
 2006
 31 S2 p. T158-
1 p.
 artikel
73 Imaging vesicular monoamine transporter sites with fluoroalkyl derivatives of dihydrotetrabenazine Hou, Catherine
 2006
 31 S2 p. T14-
1 p.
 artikel
74 Impact of presynaptic dopamine activity on D1 radiotracer binding in vivo in rodent brain Guo, Ningning
 2006
 31 S2 p. T115-
1 p.
 artikel
75 Increasing the accuracy of in vivo quantification of dopamine-D2/D3 receptor binding in the human brain by partial volume effect correction Sovago, Judit
 2006
 31 S2 p. T85-
1 p.
 artikel
76 INER, a subnanomolar affinity ligand for the norepinephrine transporter: In vivo characterization in subhuman primates Tamagnan, Gilles
 2006
 31 S2 p. T137-
1 p.
 artikel
77 In-target produced [11C]methane meets the demands of increased specific radioactivity for neuroreceptor PET radioligands Andersson, Jan
 2006
 31 S2 p. T44-
1 p.
 artikel
78 Interventional studies for validation of non-invasive dual-tracer PET Koeppe, Robert A.
 2006
 31 S2 p. T60-
1 p.
 artikel
79 In vitro characterisation of the high affinity D2/D3 dopamine agonist (+)PhNO Parker, Christine
 2006
 31 S2 p. T29-
1 p.
 artikel
80 In vivo and in vitro measurement of brain phosphodiesterase 4 in rats after antidepressant treatment Fujita, M.
 2006
 31 S2 p. T143-
1 p.
 artikel
81 In vivo characterization in non-human primates of βFE m ZIENT and βFE mZBrENT: New serotonin transporter imaging agents: effects of selective monoamine transporter displacement using microPET Goodman, Mark
 2006
 31 S2 p. T27-
1 p.
 artikel
82 In vivo characterization in subhuman primates of mZIENT: A new serotonin transporter, effects of selective SERT displacement Gilles, Tamagnan
 2006
 31 S2 p. T131-
1 p.
 artikel
83 In vivo evaluation and quantification of the 5-HT4 receptor PET ligand [11C]SB-207145 Comley, Robert
 2006
 31 S2 p. T23-
1 p.
 artikel
84 In vivo imaging of microglial activation using a peripheral benzodiazepine receptor ligand, [11C]PK11195 and animal PET following implantation of cultured activated microglia into rat striatum Kudo, Gen
 2006
 31 S2 p. T148-
1 p.
 artikel
85 In vivo occupancy of alpha4beta2* nicotinic acetylcholine receptors (nAChRs) by nicotine: PET study with 2-[18F]FA in non-human primates and humans Chefer, Svetlana
 2006
 31 S2 p. T25-
1 p.
 artikel
86 In-vivo occupancy studies with rat DTBZ+ data using a microPET® Focus 120 Sossi, Vesna
 2006
 31 S2 p. T140-
1 p.
 artikel
87 In vivo quantification of the greater densities of alpha4beta2* nicotinic acetylcholine receptors in smokers compared to non-smokers Kimes, Alane S.
 2006
 31 S2 p. T153-
1 p.
 artikel
88 Isoflurane increases both the specific binding ratio and sensitivity to amphetamine challenge of [11C]-(+)-PHNO McCormick, Patrick N.
 2006
 31 S2 p. T33-
1 p.
 artikel
89 Kinetic analysis of [11C]MP4A for measurement of cerebral acetylcholine esterase activity without arterial blood sampling Florea, Ioana
 2006
 31 S2 p. T126-
1 p.
 artikel
90 Kinetic and metabolic evaluation of new PET ligands for peripheral benzodiazepine receptors Imaizumi, M.
 2006
 31 S2 p. T135-
1 p.
 artikel
91 Kinetic modelling of [11C]flumazenil using model-driven and data-driven methods Stangier, Isabelle
 2006
 31 S2 p. T97-
1 p.
 artikel
92 Labeling of a high affinity mGluR5 ligand with fluorine-18 in either of two positions for comparative evaluation as radioligands in monkey with PET Siméon, Fabrice G.
 2006
 31 S2 p. T49-
1 p.
 artikel
93 Lifting wavelet transform for denoising PET time–activity curves: Effect on kinetic analyses Yaqub, Maqsood
 2006
 31 S2 p. T65-
1 p.
 artikel
94 Longitudinal assessment of beta2-nicotinic acetylcholine receptor availability in abstinent smokers: A [I-123]5-IA-85380 SPECT imaging study Cosgrove, Kelly
 2006
 31 S2 p. T155-
1 p.
 artikel
95 Longitudinal assessment of cerebral 5-HT2A receptors in normal volunteers. An [18F]-altanserin PET study Marner, Lisbeth
 2006
 31 S2 p. T101-
1 p.
 artikel
96 Longitudinal evaluation of a preclinical model of Huntington disease using molecular imaging techniques and selected radioligands Moresco, Rosa Maria
 2006
 31 S2 p. T34-
1 p.
 artikel
97 Measurement of glycine binding site of N-methyl-d-aspartate (NMDA) receptors in living human brain using 4-Acetoxy derivative of l-703,717, 4-Acetoxy-7-chloro-3-[3-(4-[11C] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with PET Matsumoto, Ryohei
 2006
 31 S2 p. T108-
1 p.
 artikel
98 Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-11C]WAY-100635—considerations on the validity of cerebellum as a reference region Hirvonen, Jussi
 2006
 31 S2 p. T127-T128
nvt p.
 artikel
99 Measuring arterial input functions for simultaneous dual tracer PET in rats Moirano, Jeffrey
 2006
 31 S2 p. T58-
1 p.
 artikel
100 Metabolite considerations in the in vivo quantification of serotonin transporters using [11C] DASB and positron emission tomography in humans Parsey, Ramin V.
 2006
 31 S2 p. T175-
1 p.
 artikel
101 Metabolite considerations in the in vivo quantification of serotonin transporters using [11C] DASB and positron emission tomography in humans Parsey, RaminV.
 2006
 31 S2 p. T181-
1 p.
 artikel
102 Microglia activation after traumatic brain injury van Berckel, Bart N.M.
 2006
 31 S2 p. T160-
1 p.
 artikel
103 MINC-based software package for the analysis of molecular neuroimaging data Winz, O.H.
 2006
 31 S2 p. T61-
1 p.
 artikel
104 Modeling of ligand–receptor interactions for a nicotinic agonist: Is it possible to discriminate multiple affinity states in vivo with PET? Gallezot, Jean-Dominique
 2006
 31 S2 p. T104-T105
nvt p.
 artikel
105 Mouse dosimetry using small animal PET Endres, Christopher
 2006
 31 S2 p. T57-
1 p.
 artikel
106 Multivariate analysis of PIB PET imaging studies Price, Julie C.
 2006
 31 S2 p. T24-
1 p.
 artikel
107 Necessary scan time to measure the distribution volume of the nicotinic acetylcholine receptor ligand 2-[F-18]F-A-85380 Herzog, Hans
 2006
 31 S2 p. T95-
1 p.
 artikel
108 Neuropeptide-Y Y5 (NPY5) receptor: occupancy studies in Rhesus monkey using a novel NPY5 PET tracer Hostetler, Eric
 2006
 31 S2 p. T16-
1 p.
 artikel
109 Neurotransmission SPECT and MR registration combining mutual and gradient information Bullich, Santi
 2006
 31 S2 p. T93-
1 p.
 artikel
110 Nicotinic acetylcholine receptors (alpha4beta2) and their relationship to cognitive and mood symptoms in Parkinson disease: A 2-[18F]-F-A-85380 PET study Meyer, Philipp
 2006
 31 S2 p. T151-
1 p.
 artikel
111 Parametric images of [11C]Flumazenil binding: Comparison of methods Klumpers, Ursula
 2006
 31 S2 p. T76-
1 p.
 artikel
112 Parametric images of 5HT1A receptor sites in human brain: Methodological evaluation of a novel method, HYPOTIME Møller, Mette
 2006
 31 S2 p. T77-T78
nvt p.
 artikel
113 Parametric imaging of [11C]MP4A: Comparison of different methods on simulated data Tomasi, G.
 2006
 31 S2 p. T80-T81
nvt p.
 artikel
114 Parametric mapping of [C-11]FLB457 binding using spectral analysis Asselin, Marie-Claude
 2006
 31 S2 p. T21-T22
nvt p.
 artikel
115 PET [11C] DASB imaging of serotonin transporters in alcoholics with and without a history of aggression Brown, Amira
 2006
 31 S2 p. T43-
1 p.
 artikel
116 PET displacement sensitivity: Predicting binding potential change for PET tracers based on their kinetic characteristics Morris, Evan
 2006
 31 S2 p. T106-
1 p.
 artikel
117 PET evaluation of the partial dopamine D1 receptor agonist radioligands R- and S-[11C]N-Methyl-NNC 01-0259 Finnema, Sjoerd
 2006
 31 S2 p. T114-
1 p.
 artikel
118 PET imaging of cerebral ischemia with a peripheral benzodiazepine receptor ligand Imaizumi, M.
 2006
 31 S2 p. T35-
1 p.
 artikel
119 PET imaging of cortical 11C-nicotine binding correlates with cognitive function of attention in Alzheimer's disease Kadir, Ahmadul
 2006
 31 S2 p. T152-
1 p.
 artikel
120 PET imaging of dopamine and serotonin in Tourette's Syndrome Wong, Dean
 2006
 31 S2 p. T180-
1 p.
 artikel
121 PET imaging of the CNS histamine H3 receptor using [11C]GSK189254A Plisson, Christophe
 2006
 31 S2 p. T47-
1 p.
 artikel
122 PET imaging of the norepinephrine transporter: A review plus new developments Ding, Yu-Shin
 2006
 31 S2 p. T136-
1 p.
 artikel
123 PET imaging of transgenic mice TG2576 using the beta-amyloid radioligand, [C-11]PIB Cai, Lisheng
 2006
 31 S2 p. T141-T142
nvt p.
 artikel
124 PET neuroimaging of racemic [11C]mirtazapine and enantiomers: Pharmacokinetic models and alpha-noradrenergic binding sites Smith, Donald Frederick
 2006
 31 S2 p. T125-
1 p.
 artikel
125 Pharmacological evaluation of the novel D2/3 agonist radiotracer [11C]-(+)-PHNO in anesthetized non-human primates: A potential D3 receptor preferring agonist? Narendran, Raj
 2006
 31 S2 p. T116-
1 p.
 artikel
126 Pharmacological selectivity of the in vivo binding of [11C]NNC 112 and [11C]SCH 23390 in the cortex: A PET study in baboons Ekelund, J.
 2006
 31 S2 p. T111-
1 p.
 artikel
127 Positive correlation between body mass index and in vivo serotonin 2A receptor binding in healthy humans Erritzoe, David
 2006
 31 S2 p. T164-
1 p.
 artikel
128 Positron emission tomography quantification of [11C]-(+)-PHNO binding to the dopamine D2/D3 receptors in the human brain Ginovart, Nathalie
 2006
 31 S2 p. T30-
1 p.
 artikel
129 PPET: A software tool for kinetic and parametric analyses of dynamic PET studies Boellaard, Ronald
 2006
 31 S2 p. T62-
1 p.
 artikel
130 Prelims for NRM abstracts 2006
 31 S2 p. T1-T11
nvt p.
 artikel
131 Quantification of alpha4beta2* nicotinic acetylcholine receptors in human brain using bolus plus infusion administration of 2-[F-18]F-A-85380 Kimes, Alane S.
 2006
 31 S2 p. T102-
1 p.
 artikel
132 Quantification of dopamine synthesis in human brain using positron emission tomography with l-[beta-11C]DOPA Ito, Hiroshi
 2006
 31 S2 p. T107-
1 p.
 artikel
133 Quantification of dopamine transporter binding using [18F]FP-β-CIT and positron emission tomography Yaqub, Maqsood
 2006
 31 S2 p. T66-
1 p.
 artikel
134 Quantification of α4β2* nicotinic acetylcholine receptors (nAChRs) in squirrel monkey brain using PET and 2FA Chefer, Svetlana
 2006
 31 S2 p. T138-
1 p.
 artikel
135 Quantification of nicotinic receptors in the rat brain with microPET® and 2-[18F]F-A-85380 Vaupel, D. Bruce
 2006
 31 S2 p. T103-
1 p.
 artikel
136 Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](−)-RWAY Yasuno, Fumihiko
 2006
 31 S2 p. T98-
1 p.
 artikel
137 Quantitative in vivo imaging of microglia activation using [11C]PK11195 and two reference tissue models Bertoldo, Alessandra
 2006
 31 S2 p. T79-
1 p.
 artikel
138 Radiosynthesis of a Histamine H3 receptor antagonist: In vitro and in vivo evaluation Airaksinen, Anu J.
 2006
 31 S2 p. T46-
1 p.
 artikel
139 Reduced cerebral DOPA uptake in adult patients suffering from phenylketonuria Landvogt, Christian
 2006
 31 S2 p. T171-
1 p.
 artikel
140 Regional variations in age dependence of P-gp-mediated transport across the blood–brain barrier measured using (R)-[11C]verapamil and PET Lubberink, Mark
 2006
 31 S2 p. T110-
1 p.
 artikel
141 Relationship between prefrontal cognitive functions and dopaminergic transmission: A [18F]-fluoro-l-DOPA PET study Vernaleken, Ingo
 2006
 31 S2 p. T172-
1 p.
 artikel
142 Reproducibility of cerebral A1 adenosine receptor equilibrium modeling using [18F]CPFPX and PET Elmenhorst, David
 2006
 31 S2 p. T122-
1 p.
 artikel
143 Robust fitting for kinetic modeling of PET data Ogden, R. Todd
 2006
 31 S2 p. T64-
1 p.
 artikel
144 Selection of a reference tissue region for [11C](R)-PK11195 studies in Alzheimer's disease Kropholler, Marc Anton
 2006
 31 S2 p. T75-
1 p.
 artikel
145 Serotonin 2A binding in healthy twins genetically predisposed to major depression in comparison with undisposed controls Frokjaer, Vibe G.
 2006
 31 S2 p. T163-
1 p.
 artikel
146 Serotonin 2A binding in neuroleptic-naive schizophrenic patients and healthy controls using PET and [18-F]altanserin Erritzøe, David
 2006
 31 S2 p. T165-
1 p.
 artikel
147 Serotonin-1A receptor binding in depression: Correlates with interleukin-6 and the hypothalamic–pituitary–adrenal axis Carlson, Paul
 2006
 31 S2 p. T173-
1 p.
 artikel
148 Serotonin transporter binding in major depressive disorder and bipolar disorder assessed using [11C]DASB and positron emission tomography Cannon, Dara M.
 2006
 31 S2 p. T42-
1 p.
 artikel
149 Serotonin transporter binding is decreased in healthy twins genetically predisposed to major depression in comparison with undisposed twins Frokjaer, Vibe G.
 2006
 31 S2 p. T183-
1 p.
 artikel
150 Simplified measurement of 2-[18F]F-A-85380 parent fraction in blood plasma during PET studies Shumway, Dean
 2006
 31 S2 p. T54-
1 p.
 artikel
151 Simplified reference tissue approach with multiple injections of [C-11]raclopride Watabe, Hiroshi
 2006
 31 S2 p. T72-
1 p.
 artikel
152 Simultaneous dual tracer PET imaging of alterations in dopamine D2 receptor occupancy and blood flow in rat brain Converse, Alexander K.
 2006
 31 S2 p. T59-
1 p.
 artikel
153 SPECT study of GABAA/BZD receptors and cerebral blood flow in mild cognitive impairment (MCI) Pappata, Sabina
 2006
 31 S2 p. T169-
1 p.
 artikel
154 Supervised reference region extraction for the quantification of [11C]-(R)-PK11195 brain studies Turkheimer, Ferico E.
 2006
 31 S2 p. T18-
1 p.
 artikel
155 Synthesis and in vivo evaluation of a new PET radioligand for imaging the cannabinoid type-1 (CB1) receptors Donohue, Sean
 2006
 31 S2 p. T50-
1 p.
 artikel
156 Synthesis of 11C-labeled (S,S)-CFMME and (R)-OHDMI and their evaluation as candidate radioligands for imaging norepinephrine transporters with PET Schou, Magnus
 2006
 31 S2 p. T48-
1 p.
 artikel
157 Synthesis of 11C-labelled alkyl halides with high specific radioactivity Eriksson, Jonas
 2006
 31 S2 p. T45-
1 p.
 artikel
158 Test–retest variability of [11C]PIB studies in healthy subjects and AD patients Tolboom, Nelleke
 2006
 31 S2 p. T100-
1 p.
 artikel
159 The high-affinity peripheral benzodiazepine receptor ligand [C-11]DAA1106 results in improved delineation of neuroinflammatory lesions in a rodent model of disease compared to [C-11]PK11195 Lopresti, Brian
 2006
 31 S2 p. T134-
1 p.
 artikel
160 To lipophilicity and beyond—towards a deeper understanding of radioligand non-specific binding Sebai, Sarra
 2006
 31 S2 p. T56-
1 p.
 artikel
161 Using reference tissue model with spatial parameter coupling to quantify the naltrexone-induced changes in [11C]diprenorphine opioid receptor binding Zhou, Yun
 2006
 31 S2 p. T74-
1 p.
 artikel
162 Validation of a method for automatic quantification of radioactivity in the globus pallidus in [11C]-(+)-PHNO PET images MartínRusjan, Pablo
 2006
 31 S2 p. T96-
1 p.
 artikel
163 Validity and value of multi-center clinical evaluation using quantitative SPECT reconstruction package (QSPECT) for I-123 radiopharmaceuticals Nakazawa, M.
 2006
 31 S2 p. T174-
1 p.
 artikel
164 What's in a binding potential: How much binding and how much potential? Gjedde, Albert
 2006
 31 S2 p. T12-
1 p.
 artikel
165 Widespread deficiency in brain serotonin transporter binding in bipolar disorder on positron emission tomography Mann, J. John
 2006
 31 S2 p. T41-
1 p.
 artikel
166 Widespread deficiency in brain serotonin transporter binding in bipolar disorder on positron emission tomography Mann, J. John
 2006
 31 S2 p. T99-
1 p.
 artikel
                             166 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland